John Marcolini Sells 267 Shares of Itron (NASDAQ:ITRI) Stock

Itron, Inc. (NASDAQ:ITRI) SVP John Marcolini sold 267 shares of Itron stock in a transaction on Wednesday, May 20th. The shares were sold at an average price of $79.60, for a total transaction of $21,253.20. Following the completion of the sale, the senior vice president directly owned 25,011 shares of the company’s stock, valued at approximately $1,990,875.60. The trade was a 1.06% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Itron Price Performance

ITRI opened at $83.02 on Friday. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24. The company has a market capitalization of $3.68 billion, a price-to-earnings ratio of 13.24, a P/E/G ratio of 0.72 and a beta of 1.35. The firm’s fifty day moving average price is $88.45 and its two-hundred day moving average price is $94.52. Itron, Inc. has a 1 year low of $77.77 and a 1 year high of $142.00.

Itron (NASDAQ:ITRI) last posted its quarterly earnings data on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.26 by $0.23. The firm had revenue of $586.98 million for the quarter, compared to the consensus estimate of $572.04 million. Itron had a net margin of 12.31% and a return on equity of 19.54%. The business’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.52 EPS. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS. As a group, analysts anticipate that Itron, Inc. will post 6.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Itron

A number of hedge funds have recently made changes to their positions in the business. Impax Asset Management Group plc raised its stake in Itron by 127.3% in the 3rd quarter. Impax Asset Management Group plc now owns 1,588,950 shares of the scientific and technical instruments company’s stock valued at $197,153,000 after acquiring an additional 890,040 shares during the period. Norges Bank bought a new stake in Itron in the 4th quarter valued at about $63,990,000. Soros Fund Management LLC bought a new stake in Itron in the 4th quarter valued at about $34,843,000. Millennium Management LLC raised its stake in Itron by 269.3% in the 4th quarter. Millennium Management LLC now owns 506,867 shares of the scientific and technical instruments company’s stock valued at $47,068,000 after acquiring an additional 369,617 shares during the period. Finally, Merewether Investment Management LP raised its stake in Itron by 1,552.7% in the 2nd quarter. Merewether Investment Management LP now owns 300,787 shares of the scientific and technical instruments company’s stock valued at $39,593,000 after acquiring an additional 282,587 shares during the period. 96.19% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on ITRI. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Itron in a report on Friday, May 8th. Oppenheimer lifted their price objective on shares of Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a report on Thursday, April 16th. Zacks Research raised shares of Itron from a “strong sell” rating to a “hold” rating in a report on Thursday, February 26th. JPMorgan Chase & Co. cut their price objective on shares of Itron from $133.00 to $113.00 and set an “overweight” rating on the stock in a report on Thursday, April 16th. Finally, Robert W. Baird set a $128.00 target price on Itron and gave the stock an “outperform” rating in a research note on Wednesday, February 18th. Eight investment analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Itron presently has an average rating of “Moderate Buy” and an average price target of $131.22.

Key Headlines Impacting Itron

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reiterated an Overweight rating on Itron and kept a $130 price target, signaling substantial upside versus recent trading levels.
• Neutral Sentiment: Several Itron executives sold small amounts of stock, but the filings say the shares were sold mainly to cover tax withholding tied to equity award vesting, which makes the insider activity look routine rather than a major red flag.
• Negative Sentiment: Zacks Research cut multiple future earnings estimates for Itron, including a sharp reduction to Q4 2027 EPS and a lower FY2027 outlook, suggesting softer profit growth ahead.

About Itron

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.